documents: FDA-2015-N-0002-0049

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2015-N-0002-0049 FDA FDA-2015-N-0002 FINDING OF NO SIGNIFICANT IMPACT AquAdvantage Salmon In support of an approval of a New Animal Drug Application related to AquAdvantage Salmon, which are triploid, hemizygous, all-female Atlantic salmon (Salmo salar) bearing a single copy of the α-form of the opAFP-GHc2 recombinant DNA construct at the α-locus in the EO-1α lineage Supporting & Related Material Background Material 2015-12-07T05:00:00Z 2015 12     2015-12-07T16:12:31Z   0 0 0900006481d8a198

Links from other tables